VRC 603: A PHASE I, DOSE-ESCALATION STUDY OF THE SAFETY OF AAV8-VRC07 (VRC-HIVAAV070-00-GT) RECOMBINANT AAV VECTOR EXPRESSING VRC07 HIV-1 NEUTRALIZING ANTIBODY IN ANTIRETROVIRAL -TREATED, HIV-1 INFECTED ADULTS WITH CONTROLLED VIREMIA.: